Antioxidant effect of estrogen on bovine aortic endothelial cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 117, Issue 1-3, 2009, Pages 74-80

  Song, Jae Yen ^a   Kim, Min Joung ^a   Jo, Hyun Hee ^a   Hwang, Seong Jin ^a   Chae, Boah ^a   Chung, Jae Eun ^b   Kwon, Dong Jin ^a   Lew, Young Ok ^a   Lim, Yong Taik ^a   Kim, Jang Heub ^a   Kim, Jin Hong ^a   Kim, Mee Ran ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Apoptosis; Bovine aortic endothelial cell; Estrogen; Hydrogen peroxide; Oxidative stress

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ESTRADIOL; ESTROGEN; HOE 33342; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIOXIDANT ACTIVITY; AORTA; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; AORTA; APOPTOSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CATTLE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MENOPAUSE; OXIDATIVE STRESS; PYRIDINES; REACTIVE OXYGEN SPECIES;

BOVINAE;

EID: 70249135668     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.07.006     Document Type: Article

References (60)

1. Col N.F., Eckman M.H., and Karas R.H. Patient-specific decisions about hormone replacement therapy in postmenopausal woman. J. Am. Med. Assoc. 277 (1997) 1140-1147
2. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speiser F.E., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from nurse's health study. New Engl. J. Med. 12 (1991) 756-762
3. Grady D., Rubin S.M., and Petitti D.B. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117 (1992) 1016-1037
4. Bush T.L. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy. Eur. Heart J. 17 Suppl. D (1996) 9-14
5. Thompson S.G., Meade T.W., and Greenburg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J. Epidemiol. Community Health 43 (1989) 173-178
6. Shah M.G., and Maibach H.I. Estrogen and skin. Am. J. Clin. Dermatol. 2 (2001) 143-150
7. Rafici V.A., and Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 41 10 (1992) 1110-1114
8. Cicinelli E., Ignarro L.J., Matteo M.G., Galantino P., Schonauer L.M., and Falco N. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am. J. Obstet. Gynecol. 180 (1999) 334-339
9. Gerhard M., and Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 92 (1995) 5-8
10. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein(a) concentrations: analysis of studies published from 1974-2000. Fertil. Steril. 75 (2001) 898-915
11. Kroon U.B., Silfverstolper G., and Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb. Haemost. 71 (1994) 420-423
12. Rossouw J.E., Anderson G.L., and Prentice P.L. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Woman's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
13. Le Gal G., Gourlet V., and Hogrel P. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women: the vascular aging (EVA) study. Atherosclerosis 166 (2003) 163-170
14. Harman S.M., Brinton E.A., Cedars M., Lobo R., Manson J.E., Merrian G.R., Miller V.M., Naftolin F., and Santoro N. KEEPS: the kronos early estrogen prevention study. Climateric 8 (2005) 3-12
15. Daviglus M.L., Lloyd-Jones D.M., and Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am. J. Cardiovasc. Drugs 6 (2006) 87-101
16. Causality of Death of General Population (1993-2003) (2004), Publication of Korean National Statistical Office
17. Samaan S.A., and Crawford M.K. Estrogen and cardiovascular function after menopause. J. Am. Coll. Cardiol. 26 (1995) 1403-1410
18. Halliwell B., and Aruoma O.I. DNA damage by oxygen-derived species its mechanism and measurement in mammalian systems. FEBS Lett. 281 (1991) 9-19
19. Li P.D., and Nijihawan D. Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (2000) 479-489
20. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
21. Tibbles L.A., and Woodgett J.R. The stress-activated protein kinase pathway. Cell. Mol. Life Sci. 122 (1999) 1251-1256
22. Bost F., Aouadi M., and Caron L. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87 (2005) 51-56
23. Park S.J., and Kim I.S. The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells. Br. J. Pharmacol. 146 (2005) 506-513
24. Aoki M., and Nata T. Endothelial apoptosis induced by oxidative stress through activation of NF-kB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38 (2001) 48-55
25. Kawauchi J., Zhang C., and Nobori K. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-induced apoptosis through down-regulation of p53 transcription. J. Biol. Chem. 277 (2002) 39025-39034
26. Scarabelli T.M., Stephanou A., and Pasini E. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ. Res. 90 (2005) 745-748
27. Muzykantov V.R. Targeting of superoxide dismutase and catalase to vascular endothelium. J. Control Rel. 71 (2001) 1-21
28. Mignotte B., and Vayssiere J.L. Mitochondria and apoptosis. Eur. J. Biochem. 252 (1998) 1-15
29. Bleich S., Kropp S., Degner D., Zerr I., Pilz J., Gleiter C.H., Otto M., Ruther E., Kretzschmar H.A., Wiltfang J., Kornhuber J., and Poser S. Creutzfeldt-Jakob disease and oxidative stress. Acta Neurol. Scand. 101 (2000) 332-334
30. Honda K., Casadesus G., Petersen R.B., Perry G., and Smith M.A. Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N.Y. Acad. Sci. 1012 (2004) 179-182
31. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of aging. Nature 408 (2000) 239-247
32. Halliwell B., and Gutteridge J.M. Free Radicals in Biology and Medicine. 3rd ed. (1999), Oxford Univ. Press
33. Ferrari R., Guardigli G., Mele D., Percoco G.F., Ceconi C., and Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr. Pharm. Des. 10 (2004) 1699-1711
34. Lopez-Farre A., and Casado S. Heart failure, redox alteration, and endothelial dysfunction. Hypertension 38 (2001) 1400-1405
35. Rossing L., and Hoffmann J. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 104 (2001) 2182-2187
36. Kanda N., and Watanabe S. 17β-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes. J. Invest. Dermatol. 120 (2003) 411-419
37. Kanda N., and Watanabe S. 17β-estradiol inhibits the production of RANTES in human keratinocytes. J. Invest. Dermatol. 120 (2003) 420-427
38. Kanda N., and Watanabe S. 17β-estradiol inhibits MCP-1 production in human keratinocytes. J. Invest. Dermatol. 120 (2003) 1058-1066
39. Adams M.R., Kaplan J.R., Manuck S.B., Koritnik D.R., Parks J.S., Wolfe M.S., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys, lack of an effect of added progesterone. Artherosclerosis 10 (1990) 1051-1057
40. Kume-Kick J., Ferris D.C., Ruso-Menna I., and Rice M.E. Enhanced oxidative stress in female rat brain after gonadectomy. Brain Res. 738 (1996) 8-14
41. Yagi K. Female hormones act as natural antioxidants-a survey of our research. Acta Biochim. Pol. 44 (1997) 701-709
42. McHugh N.A., Merrill G.F., and Powell S.R. Estrogen diminishes hydroxyl radical production. Am. J. Physiol. 274 (1998) 1950-1954
43. Ejima K., Nanri H., Araki M., Uchida K., Kashimura M., and Ikeda M. 17beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. Eur. J. Endocrinol. 140 (1999) 608-613
44. Dias-Flores M., Baiza-Gutman L.A., Pedron N.N., and Hick J.J. Uterine glutathione reductase activity: modulation by estrogen and progesterone. Life Sci. 65 (1999) 2481-2488
45. Kasinski K., Spyridopoulos I., Asahara T., Zee R., Isner J.M., and Losordo D.W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95 (1997) 1768-1772
46. Cobb M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71 (1999) 479-500
47. Callsen D., and Brune B. Role of mitogen-activated protein kinases in S-nitrosoflutathione-induced macrophage apoptosis. Biochemistry 38 (1999) 2279-2286
48. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
49. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., and Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tryosine and threonine. J. Biol. Chem. 270 (1995) 7420-7426
50. Ali N., Yoshizumi M., Tsuchiya K., Kyaw M., Fujita Y., Izawa Y., Abe S., Kanematsu Y., Kagami S., and Tamaki T. Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide. Eur. J. Pharmacol. 485 (2004) 127-135
51. Kondoh K., Torii S., and Nishida E. Control of MAP kinase signaling to the nucleus. Chromosoma 114 (2005) 86-91
52. Houle F., and Huot J. Dysregulation of the endothelial cellular response to oxidative stress in cancer. Mol. Carcinog. 45 (2006) 362-367
53. Stice J.P., Lee J.S., Pechenino A.S., and Knowlton A.A. Estrogen, aging and the cardiovascular system. Future Cardiol. 5 (2009) 93-103
54. Joy S., Siow R.C., Rowlands D.J., Becker M., Wyatt A.W., Aaronson P.I., Coen C.W., Kallo I., Jacob R., and Mann J.E. The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J. Biol. Chem. 281 (2006) 27335-27345
55. Arnal J.F., Gourdy P., Elhage R., Garmy-Susini B., Delmas E., Brouchet L., Castano C., Barreira Y., Couloumiers J.C., Prats H., Prats A.C., and Bayard F. Estrogens and atherosclerosis. Eur. J. Endocrinol. 150 (2004) 113-117
56. Maccarrone M., Bari M., Battista N., and Finazzi-Agrò A. Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 100 (2002) 4040-4048
57. Smith L.H., Coats S.R., Qin H., Petrie M.S., Covington J.W., Su M., Eren M., and Vaughan D.E. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells. Circ. Res. 95 (2004) 269-275
58. Lui W.L., Guo X., and Guo Z.G. Estrogen prevents bovine aortic endothelial cells from TNF-alpha-induced apoptosis via opposing effects on p38 and p44/42 CCDPK. Acta Pharmacol. Sin. 23 (2002) 213-218
59. 2-induced apoptosis via co-modulatory effects on p38-and p42/p44-CCDPK signaling. Acta Pharmacol. Sin. 23 (2002) 45-49
60. Koga M., Hirano K., Hirano M., Nishimura J., Nakano H., and Kanaide H. Akt plays a central role in the anti-apoptotic effect of estrogen in endothelial cells. Biochem. Biophys. Res. Commun. 324 (2004) 321-325